Cargando…

Targeting miR‐193a‐AML1‐ETO‐β‐catenin axis by melatonin suppresses the self‐renewal of leukaemia stem cells in leukaemia with t (8;21) translocation

AML1‐ETO, the most common fusion oncoprotein by t (8;21) in acute myeloid leukaemia (AML), enhances hematopoietic self‐renewal and leukemogenesis. However, currently no specific therapies have been reported for t (8;21) AML patients as AML1‐ETO is still intractable as a pharmacological target. For t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Bin, Ye, Haige, Xing, Chongyun, Liang, Bin, Li, Haiying, Chen, Linling, Huang, Xingzhou, Wu, Yanfei, Gao, Shenmeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653044/
https://www.ncbi.nlm.nih.gov/pubmed/31119862
http://dx.doi.org/10.1111/jcmm.14399
_version_ 1783438577541054464
author Zhou, Bin
Ye, Haige
Xing, Chongyun
Liang, Bin
Li, Haiying
Chen, Linling
Huang, Xingzhou
Wu, Yanfei
Gao, Shenmeng
author_facet Zhou, Bin
Ye, Haige
Xing, Chongyun
Liang, Bin
Li, Haiying
Chen, Linling
Huang, Xingzhou
Wu, Yanfei
Gao, Shenmeng
author_sort Zhou, Bin
collection PubMed
description AML1‐ETO, the most common fusion oncoprotein by t (8;21) in acute myeloid leukaemia (AML), enhances hematopoietic self‐renewal and leukemogenesis. However, currently no specific therapies have been reported for t (8;21) AML patients as AML1‐ETO is still intractable as a pharmacological target. For this purpose, leukaemia cells and AML1‐ETO‐induced murine leukaemia model were used to investigate the degradation of AML1‐ETO by melatonin (MLT), synthesized and secreted by the pineal gland. MLT remarkedly decreased AML1‐ETO protein in leukemic cells. Meanwhile, MLT induced apoptosis, decreased proliferation and reduced colony formation. Furthermore, MLT reduced the expansion of human leukemic cells and extended the overall survival in U937T‐AML1‐ETO‐xenografted NSG mice. Most importantly, MLT reduced the infiltration of leukaemia blasts, decreased the frequency of leukaemia stem cells (LSCs) and prolonged the overall survival in AML1‐ETO‐induced murine leukaemia. Mechanistically, MLT increased the expression of miR‐193a, which inhibited AML1‐ETO expression via targeting its putative binding sites. Furthermore, MLT decreased the expression of β‐catenin, which is required for the self‐renewal of LSC and is the downstream of AML1‐ETO. Thus, MLT presents anti‐self‐renewal of LSC through miR‐193a‐AML1‐ETO‐β‐catenin axis. In conclusion, MLT might be a potential treatment for t (8;21) leukaemia by targeting AML1‐ETO oncoprotein.
format Online
Article
Text
id pubmed-6653044
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66530442019-08-01 Targeting miR‐193a‐AML1‐ETO‐β‐catenin axis by melatonin suppresses the self‐renewal of leukaemia stem cells in leukaemia with t (8;21) translocation Zhou, Bin Ye, Haige Xing, Chongyun Liang, Bin Li, Haiying Chen, Linling Huang, Xingzhou Wu, Yanfei Gao, Shenmeng J Cell Mol Med Original Articles AML1‐ETO, the most common fusion oncoprotein by t (8;21) in acute myeloid leukaemia (AML), enhances hematopoietic self‐renewal and leukemogenesis. However, currently no specific therapies have been reported for t (8;21) AML patients as AML1‐ETO is still intractable as a pharmacological target. For this purpose, leukaemia cells and AML1‐ETO‐induced murine leukaemia model were used to investigate the degradation of AML1‐ETO by melatonin (MLT), synthesized and secreted by the pineal gland. MLT remarkedly decreased AML1‐ETO protein in leukemic cells. Meanwhile, MLT induced apoptosis, decreased proliferation and reduced colony formation. Furthermore, MLT reduced the expansion of human leukemic cells and extended the overall survival in U937T‐AML1‐ETO‐xenografted NSG mice. Most importantly, MLT reduced the infiltration of leukaemia blasts, decreased the frequency of leukaemia stem cells (LSCs) and prolonged the overall survival in AML1‐ETO‐induced murine leukaemia. Mechanistically, MLT increased the expression of miR‐193a, which inhibited AML1‐ETO expression via targeting its putative binding sites. Furthermore, MLT decreased the expression of β‐catenin, which is required for the self‐renewal of LSC and is the downstream of AML1‐ETO. Thus, MLT presents anti‐self‐renewal of LSC through miR‐193a‐AML1‐ETO‐β‐catenin axis. In conclusion, MLT might be a potential treatment for t (8;21) leukaemia by targeting AML1‐ETO oncoprotein. John Wiley and Sons Inc. 2019-05-22 2019-08 /pmc/articles/PMC6653044/ /pubmed/31119862 http://dx.doi.org/10.1111/jcmm.14399 Text en © 2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zhou, Bin
Ye, Haige
Xing, Chongyun
Liang, Bin
Li, Haiying
Chen, Linling
Huang, Xingzhou
Wu, Yanfei
Gao, Shenmeng
Targeting miR‐193a‐AML1‐ETO‐β‐catenin axis by melatonin suppresses the self‐renewal of leukaemia stem cells in leukaemia with t (8;21) translocation
title Targeting miR‐193a‐AML1‐ETO‐β‐catenin axis by melatonin suppresses the self‐renewal of leukaemia stem cells in leukaemia with t (8;21) translocation
title_full Targeting miR‐193a‐AML1‐ETO‐β‐catenin axis by melatonin suppresses the self‐renewal of leukaemia stem cells in leukaemia with t (8;21) translocation
title_fullStr Targeting miR‐193a‐AML1‐ETO‐β‐catenin axis by melatonin suppresses the self‐renewal of leukaemia stem cells in leukaemia with t (8;21) translocation
title_full_unstemmed Targeting miR‐193a‐AML1‐ETO‐β‐catenin axis by melatonin suppresses the self‐renewal of leukaemia stem cells in leukaemia with t (8;21) translocation
title_short Targeting miR‐193a‐AML1‐ETO‐β‐catenin axis by melatonin suppresses the self‐renewal of leukaemia stem cells in leukaemia with t (8;21) translocation
title_sort targeting mir‐193a‐aml1‐eto‐β‐catenin axis by melatonin suppresses the self‐renewal of leukaemia stem cells in leukaemia with t (8;21) translocation
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653044/
https://www.ncbi.nlm.nih.gov/pubmed/31119862
http://dx.doi.org/10.1111/jcmm.14399
work_keys_str_mv AT zhoubin targetingmir193aaml1etobcateninaxisbymelatoninsuppressestheselfrenewalofleukaemiastemcellsinleukaemiawitht821translocation
AT yehaige targetingmir193aaml1etobcateninaxisbymelatoninsuppressestheselfrenewalofleukaemiastemcellsinleukaemiawitht821translocation
AT xingchongyun targetingmir193aaml1etobcateninaxisbymelatoninsuppressestheselfrenewalofleukaemiastemcellsinleukaemiawitht821translocation
AT liangbin targetingmir193aaml1etobcateninaxisbymelatoninsuppressestheselfrenewalofleukaemiastemcellsinleukaemiawitht821translocation
AT lihaiying targetingmir193aaml1etobcateninaxisbymelatoninsuppressestheselfrenewalofleukaemiastemcellsinleukaemiawitht821translocation
AT chenlinling targetingmir193aaml1etobcateninaxisbymelatoninsuppressestheselfrenewalofleukaemiastemcellsinleukaemiawitht821translocation
AT huangxingzhou targetingmir193aaml1etobcateninaxisbymelatoninsuppressestheselfrenewalofleukaemiastemcellsinleukaemiawitht821translocation
AT wuyanfei targetingmir193aaml1etobcateninaxisbymelatoninsuppressestheselfrenewalofleukaemiastemcellsinleukaemiawitht821translocation
AT gaoshenmeng targetingmir193aaml1etobcateninaxisbymelatoninsuppressestheselfrenewalofleukaemiastemcellsinleukaemiawitht821translocation